Atopic Dermatitis Market Predictable to Demand Drivers and Growth Stimulators

According to the report published by the National Center for Biotechnology Information, and atopic dermatitis has affected around 20% of infants and children and 3% of adults at a global level. There has been rising funding along with government support for the research and development boosting the growth of the atopic dermatitis market. Atopic dermatitis global market report showcases that the market will grow at a CAGR of 8.2% during the forecast period of 2017-2023. 

The type of eczema has various patterns that depend on the age of the patients. It can occur anywhere in the body and can be characterized by a low quantity of filaggrin protein that allows for the skin to become dry and reduces the immunity ability.

The market for this type of eczema is growing majorly, attributing to the prevalence of atopic disorders and the various technological developments in the medical devices field.

Market segmentation

The global atopic dermatitis market has been presented with the growing rate of the global market at a faster rate. The report also presents a detailed analysis of dermatitis that can be segmented based on the types, applications, and end-users.

On the basis of the type, the global market can be split into:

Monoclonal antibodies

  • Hormone
  • Erythropoietin
  • Calcitonin
  • Interferon
  • Others

And based on the applications, the global atopic dermatitis market can be classified into:

  • Chronic diseases
  • Cancer
  • Blood disorders
  • Infectious diseases
  • others


Be the first to comment

Please check your e-mail for a link to activate your account.